| Name | Title | Contact Details |
|---|
Versamedical is a Pearl River, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Msssie Research Labs is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Landauer is committed to providing unrivaled radiation monitoring service and to ongoing discovery for improving radiation safety Landauer is the global leader in radiation science and services. We provide tools and support to organizations with potential exposure to ionizing radiation, helping them achieve their radiation safety goals. Our proprietary, state-of-the-art optically stimulated luminescence (OSL) technology enables the most precise measurements possible for occupational radiation monitoring and environmental monitoring and a full range of specialized applications including machine quality assurance and patient radiation monitoring. We back our advanced technology with the most flexible dosimetry programs and best customer service the industry has to offer. While technology continues to advance, one thing is certain with each innovation we must also focus on identifying and mitigating any potential risks related to the benefits. As the first organization to recognize and address radiation risks, and with a sustained history of innovation and dedication unequaled in the industry, LANDAUER is uniquely poised to lead this quest for improved personal and public health and safety across the globe.
Biosearch Medical Products is a Branchburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.